Literature DB >> 10817442

Migraine patients show an increased density of dopamine D3 and D4 receptors on lymphocytes.

P Barbanti1, G Fabbrini, A Ricci, M P Pascali, E Bronzetti, F Amenta, G L Lenzi, R Cerbo.   

Abstract

Recent studies have revealed peculiar functional and genetic features of dopamine receptors in migraine. As peripheral blood lymphocytes (PBL) may represent a tool for peripheral detection of neuroreceptors, we compared the expression of dopamine D3 (DRD3) and D4 (DRD4) receptors on PBL in migraine patients and in healthy controls using radioligand binding assay techniques in the presence of antidopamine D2-like receptor antibodies. The dopamine D2-like receptor agonist [3H]7-OH-DPAT was used as a radioligand. An increased density of both DRD3 (P=0.0006) and DRD4 (P=0.002) on PBL was observed in migraineurs compared with controls. This up-regulation might reflect central and/or peripheral dopamine receptor hypersensitivity due to hypofunction of the dopaminergic system. These findings support the view that dopamine D2-like receptors are involved in the determination of the so-called migraine trait, which may help to elucidate several clinical features of the disease.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10817442     DOI: 10.1046/j.1468-2982.2000.00001.x

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  8 in total

1.  Is the dopamine D3 receptor mRNA on blood lymphocytes help to for identification and subtyping of schizophrenia?

Authors:  M Urhan-Kucuk; M E Erdal; M E Ozen; S Kul; H Herken
Journal:  Mol Biol Rep       Date:  2010-11-26       Impact factor: 2.316

Review 2.  Current and prospective pharmacological targets in relation to antimigraine action.

Authors:  Suneet Mehrotra; Saurabh Gupta; Kayi Y Chan; Carlos M Villalón; David Centurión; Pramod R Saxena; Antoinette MaassenVanDenBrink
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-07-15       Impact factor: 3.000

Review 3.  Dopaminergic symptoms in migraine.

Authors:  Piero Barbanti; L Fofi; C Aurilia; G Egeo
Journal:  Neurol Sci       Date:  2013-05       Impact factor: 3.307

4.  Dopamine receptors in human lymphocytes: radioligand binding and quantitative RT-PCR assays.

Authors:  Galina P Kirillova; Rebecca J Hrutkay; Michael R Shurin; Galina V Shurin; Irina L Tourkova; Michael M Vanyukov
Journal:  J Neurosci Methods       Date:  2008-08-05       Impact factor: 2.390

Review 5.  Psychiatric comorbidities of episodic and chronic migraine.

Authors:  Dawn C Buse; Stephen D Silberstein; Aubrey N Manack; Spyros Papapetropoulos; Richard B Lipton
Journal:  J Neurol       Date:  2012-11-07       Impact factor: 4.849

6.  The dopaminergic system in peripheral blood lymphocytes: from physiology to pharmacology and potential applications to neuropsychiatric disorders.

Authors:  Francesca R Buttarelli; Alessandra Fanciulli; Clelia Pellicano; Francesco E Pontieri
Journal:  Curr Neuropharmacol       Date:  2011-06       Impact factor: 7.363

7.  Studies on the pathophysiology and genetic basis of migraine.

Authors:  Claudia F Gasparini; Heidi G Sutherland; Lyn R Griffiths
Journal:  Curr Genomics       Date:  2013-08       Impact factor: 2.236

Review 8.  A link between gastrointestinal disorders and migraine: Insights into the gut-brain connection.

Authors:  Sheena K Aurora; Stephen B Shrewsbury; Sutapa Ray; Nada Hindiyeh; Linda Nguyen
Journal:  Headache       Date:  2021-04-01       Impact factor: 5.887

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.